Identification of potent biodegradable adjuvants that efficiently break self-tolerance--a key issue in the development of therapeutic vaccines.

[1]  P. Schneider,et al.  Cracking the BAFF code , 2009, Nature Reviews Immunology.

[2]  F. Sugauchi,et al.  Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants. , 2008, Vaccine.

[3]  K. Ishii,et al.  Intracellular DNA sensors in immunity. , 2008, Current opinion in immunology.

[4]  L. Hellman.  Therapeutic vaccines against IgE-mediated allergies , 2008, Expert review of vaccines.

[5]  A. Burny,et al.  Control of allergic reactions in mice by an active anti-murine IL-4 immunization. , 2007, Vaccine.

[6]  F. Simons,et al.  Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice. , 2007, American journal of respiratory and critical care medicine.

[7]  J. Gottenberg,et al.  Dendritic cells and interferon-mediated autoimmunity. , 2007, Biochimie.

[8]  F. Simons,et al.  Novel cytokine peptide‐based vaccines: an interleukin‐4 vaccine suppresses airway allergic responses in mice , 2007, Allergy.

[9]  M. Lahoz,et al.  Evaluation of Omalizumab From a Health Plan Perspective , 2005, Journal of managed care pharmacy : JMCP.

[10]  T. Powles,et al.  Phase I study of TNFα AutoVaccIne in Patients with metastatic cancer , 2005, Cancer Immunology, Immunotherapy.

[11]  A. Ledin,et al.  Identification of adjuvants that enhance the therapeutic antibody response to host IgE. , 2004, Vaccine.

[12]  R. Gallo,et al.  Anti-cytokine Ab immune therapy: present status and perspectives. , 2004, Drug discovery today.

[13]  D. Leach,et al.  HER-2 DNA and Protein Vaccines Containing Potent Th Cell Epitopes Induce Distinct Protective and Therapeutic Antitumor Responses in HER-2 Transgenic Mice , 2003, The Journal of Immunology.

[14]  A. Ledin,et al.  Generation of therapeutic antibody responses against IgE through vaccination , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  P. Foster,et al.  Active Vaccination Against IL-5 Bypasses Immunological Tolerance and Ameliorates Experimental Asthma1 , 2001, The Journal of Immunology.

[16]  L. Babiuk,et al.  CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. , 2001, Antisense & nucleic acid drug development.

[17]  M. Feldmann,et al.  Therapeutic antibodies elicited by immunization against TNF-α , 1999, Nature Biotechnology.

[18]  L. Hellman,et al.  Evidence for an early appearance of modern post‐switch isotypes in mammalian evolution; cloning of IgE, IgG and IgA from the marsupial Monodelphis domestica , 1998, European journal of immunology.

[19]  A. Krieg,et al.  CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. , 1998, Journal of immunology.

[20]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[21]  L. Hellman.  Profound reduction in allergen sensitivity following treatment with a novel allergy vaccine , 1994, European journal of immunology.

[22]  T. Andronova,et al.  The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants. , 1992, AIDS research and human retroviruses.

[23]  L. Hellman,et al.  Structure and evolution of the heavy chain from rat immunoglobulin E. , 1982, Nucleic acids research.

[24]  L. Hellman.  Vaccines Against Allergies , 1999 .